You are here

Imaging

Imaging modalities are becoming one of the most effective means of detecting cancer and a crucial component of patient care. In 2019, following a strategic review of our investment in this key research area CRUK supported a 5 year award to establish the National Cancer Imaging Translational Accelerator (NCITA). This 5 year initiative brings together leading national centres to accelerate the standardisation and clinical translation of cancer imaging biomarkers to improve diagnosis and healthcare outcomes for patients. The NCITA partners are:

  • The University of Oxford
  • The Institute of Cancer Research, London
  • King’s College London
  • University College London
  • The University of Cambridge
  • The University of Manchester
  • Imperial College
  • The University of Glasgow
  • Newcastle University

Through this network we are supporting an initial portfolio of exemplar projects. We have exclusive commercialisation rights to any IP arising from these projects funded through this initiative. Our Translational Managers and Business Development Managers work closely with the NCITA Leaders to establish the best commercial model to ensure new discoveries become available to people with cancer.

However, a key goal of the network is to establish the necessary infrastructure to facilitate translation of novel projects in collaboration with external partners. The NCITA team are keen to discuss new projects, and more information can be found at https://ncita.org.uk/

CRUK also supports imaging research from scientists, clinicians or healthcare workers across UK institutions via its Biomarker Awards and Early Detection Funding Schemes. Our Translational Managers and Business Development Managers are actively involved in the evaluation of applications and CRUK has exclusive commercialisation rights to any IP arising from these programmes.

CRUK has a strong track record of funding cancer imaging research. From 2008 to 2018 CRUK and the Engineering and Physical Sciences Research Council (EPSRC) co-funded a strategic initiative to establish the UK as a world leader in cancer imaging research. Through a joint investment of approximately £80m over these 10 years, four cancer imaging centres were established:

  • The University of Oxford
  • The Institute of Cancer Research, London
  • A joint imaging centre between King’s College London and University College London
  • A joint imaging centre between the University of Cambridge and the University of Manchester

While this initiative finished in 2018, CRUK has continued to provide significant support for cancer imaging research across these institutions through the afore mentioned National Cancer Imaging Translational Accelerator Award.